Literature DB >> 11323741

Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.

I M Fierro1, C N Serhan.   

Abstract

Multicellular host responses to infection, injury or inflammatory stimuli lead to the formation of a broad range of chemical mediators by the host. The integrated response of the host is essential to health and disease; thus it is important to achieve a more complete understanding of the molecular and cellular events governing the formation and actions of endogenous mediators of resolution that appear to control the duration of inflammation. Lipoxins are trihydroxytetraene-containing lipid mediators that can be formed during cell-cell interactions and are predominantly counterregulators of some well-known mediators of inflammation. Since this circuit of lipoxin formation and action appears to be of physiological relevance for the resolution of inflammation, therapeutic modalities targeted at this system are likely to have fewer unwanted side effects than other candidates and current anti-inflammatory therapies. Here, we present an overview of the recent knowledge about the biosynthesis and bioactions of these anti-inflammatory lipid mediators.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323741     DOI: 10.1590/s0100-879x2001000500002

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  18 in total

1.  Lipoxin A4 inhibits lipopolysaccharide-induced production of inflammatory cytokines in keratinocytes by up-regulating SOCS2 and down-regulating TRAF6.

Authors:  Feng Hu; Ai-Ping Feng; Xin-Xin Liu; Song Zhang; Jun-Tao Xu; Xin Wang; Xue-Lian Zhong; Meng-Wen He; Hong-Xiang Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

Review 2.  Patatin-like phospholipases in microbial infections with emerging roles in fatty acid metabolism and immune regulation by Apicomplexa.

Authors:  Sarah K Wilson; Laura J Knoll
Journal:  Mol Microbiol       Date:  2017-11-23       Impact factor: 3.501

3.  Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes.

Authors:  Marcelo O Freire; Jesmond Dalli; Charles N Serhan; Thomas E Van Dyke
Journal:  J Immunol       Date:  2016-12-19       Impact factor: 5.422

Review 4.  The role of dyslipidemia in diabetic retinopathy.

Authors:  Sandra S Hammer; Julia V Busik
Journal:  Vision Res       Date:  2017-05-26       Impact factor: 1.886

5.  Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.

Authors:  Alexandra I Medeiros; Anderson Sá-Nunes; Edson G Soares; Camila M Peres; Célio L Silva; Lúcia H Faccioli
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

6.  Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study.

Authors:  Kathryn P Burdon; Megan E Rudock; Allison B Lehtinen; Carl D Langefeld; Donald W Bowden; Thomas C Register; Yongmei Liu; Barry I Freedman; J Jeffrey Carr; Catherine C Hedrick; Stephen S Rich
Journal:  Mediators Inflamm       Date:  2010-05-31       Impact factor: 4.711

7.  Long-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in rats.

Authors:  Ibrahim Akyazi; Evren Eraslan; Ahmet Gülçubuk; Elif Ergül Ekiz; Zeynep L Cırakli; Damla Haktanir; Deniz Aktaran Bala; Mete Ozkurt; Erdal Matur; Mukaddes Ozcan
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

8.  Protective effect of the ω-3 polyunsaturated fatty acids on the schistosomiasis liver fibrosis in mice.

Authors:  Yuan Wu; Yu Liang; Yi Zhu; Yongqiang Gao; Hu Chen; Yukuai Zhang; Weiguo Yin; Yingju Li; Kegeng Wang; Jianhua Xiao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression.

Authors:  Nina Kim; Katie L Lannan; Thomas H Thatcher; Stephen J Pollock; Collynn F Woeller; Richard P Phipps
Journal:  J Immunol       Date:  2018-10-22       Impact factor: 5.422

10.  Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.

Authors:  Rafael F Guilherme; Debora G Xisto; Steven L Kunkel; Célio G Freire-de-Lima; Patricia R M Rocco; Josiane S Neves; Iolanda M Fierro; Claudio Canetti; Claudia F Benjamim
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.